EURETINA 2022: Stepping into a new era in ophthalmology
The 22nd European Society of Retina Specialists Congress kicks off Thursday at the Congress Centre Hamburg in Hamburg, Germany.
Study targets intravitreal injections for AMD, PCR risks
Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery.
Providing virtual care for diabetic eye disease patients
Tunde Peto, MD, offers advice on how to create the best virtual environment for patients diagnosed with diabetic eye disease.
Retinal detachments: managing retinal folds, role of anterior vitreous
Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.
Investigating suitable naïve versus pre-treated DME patients
Javier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.
AI: Capturing more information from OCT in wet AMD
Anat Loewenstein, MD, MHA, discusses how artificial intelligence can optimize optical coherence tomography.
Challenges of treating peripheral hemorrhagic polypoidal choroidal vasculopathy
A case study details the care of a patient who had already lost vision in one eye from a similar issue.
Analyzing macula dystrophy classifications
Carel B. Hoyng, MD, discusses his presenation regarding macula dystrophies, including Stargardt disease, Best disease, X-linked retinoschisis, and the peripherin-2 (PRPH2) gene.
Optogenetic therapy: Gene-independent therapeutic strategies for retinal degeneration
José-Alain Sahel, MD, explains how optogenetics involves artificial photoreceptors from specific retinal cells to restore vision.
Exploring the pathology of myopia from a global perspective
Ramin Tadayoni, MD, PhD, discusses the pathology of myopia around the globe.
Should anti-VEGF agents be used to treat NPDR patients?
Jennifer Sun, MD, MPH, explores the question of whether ophthalmologists should be using anti-VEGF agents to treat patients with nonproliferative diabetic retinopathy (NPDR).
EURETINA 2021 offers virtual education for retina specialists
The EURETINA 2021 Virtual Meeting is scheduled for Sept. 9 to 12, and retina specialists eagerly await the showcase of cutting-edge scientific developments.
2 Clarke Drive Cranbury, NJ 08512